AI Article Synopsis

Article Abstract

Objective: To study patients with autosomal recessive pseudohypoaldosteronism type 1 and to relate pulmonary disease to gene mutations of the epithelial sodium channel (ENaC).

Study Design: Clinical and laboratory data were collected from 4 Swedish patients with pseudohypoaldosteronism type 1. The genes for ENaC and cystic fibrosis transmembrane conductance regulator were analyzed for mutations with methods including DNA sequencing.

Results: Three novel mutations were found in the alpha-gene of ENaC, 2 frameshifts (1449delC and 729delA) and 1 missense mutation resulting in the substitution of leucine for serine 562 in the alpha-chain (S562L). The 1449delC mutation was found in all patients in either homozygous or heterozygous form and seems to be the predominant cause of pseudohypoaldosteronism in Sweden. The allele coding for S562L also contained a transition converting tryptophan 493 to arginine (W493R), which seems to be a rare polymorphism. All patients had pulmonary symptoms to various degrees. The bacterial findings resembled, to some extent, those in cystic fibrosis, but development of chronic lung disease and progressive decline in lung function were not observed.

Conclusions: Genetic deficiencies of the alpha subunit of the ENaC are associated with prominent lung symptoms, which are, however, clearly different from those in cystic fibrosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-3476(99)70094-6DOI Listing

Publication Analysis

Top Keywords

pseudohypoaldosteronism type
12
cystic fibrosis
12
lung symptoms
8
epithelial sodium
8
sodium channel
8
lung
4
pseudohypoaldosteronism
4
symptoms pseudohypoaldosteronism
4
type associated
4
associated deficiency
4

Similar Publications

Article Synopsis
  • Renal pseudohypoaldosteronism type 1 (PHA1) is a rare condition mainly affecting infants, resulting in symptoms like vomiting and weight loss due to dysfunctional mineralocorticoid receptors caused by gene variants in NR3C2.
  • A study on four adults with PHA1 revealed they had elevated plasma aldosterone but normal sodium levels, with one individual showing increased plasma renin.
  • The findings suggest that PHA1 is asymptomatic in adulthood, and individuals often have favorable long-term health outcomes.
View Article and Find Full Text PDF

Pseudohypoaldosteronism type II and sensory neuropathy associated with a heterozygous pathogenic variant in KLHL3 gene, a case report.

Heliyon

November 2024

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neuroscience and Cognition, F-59000, Lille, France.

Pseudohypoaldosteronism type II is a rare Mendelian disorder characterized by hypertension, hyperkalemia, hyperchloremia and metabolic acidosis, despite a normal glomerular filtration rate. Four genes (, , and ) are associated with this disease. Mutations in the gene cause pseudohypoaldosteronism type II in either an autosomal dominant or a recessive inheritance pattern.

View Article and Find Full Text PDF

Pseudohypoaldosteronism type 2 (PHA2) is a rare inherited condition of altered tubular salt handling. It is characterized by the specific constellation of hyperkalaemic hyporeninemic hypertension, hyperchloremic metabolic acidosis and hypercalciuria. Molecular genetic testing confirms the diagnosis in the majority of cases.

View Article and Find Full Text PDF

Pulmonary manifestations of Pseudohypoaldosteronism type 1b: A systematic review of the literature.

Paediatr Respir Rev

September 2024

Division of Pediatric Pulmonology, First Department of Pediatrics, National and Kapodistrian University of Athens, School of Medicine and Agia, Sofia Children's Hospital, Athens, Greece.

Introduction: Pseudohypoaldosteronism type 1b (PHA1B) is a rare autosomal recessive disease caused by dysfunction of amiloride-sensitive epithelial sodium channels (ENaC), that might present with a wide variety of pulmonary symptoms.

Methods: We provide a systematic review of published cases with PHA1B and respiratory symptoms, adding a relevant case from our clinic.

Results: Thirty-seven publications presenting 61 cases were identified apart from our case.

View Article and Find Full Text PDF

Pseudohypoaldosteronism type 1 (PHA1) is a rare, heterogeneous group of disorders characterized by resistance to aldosterone action. We report the case of a 17-day-old Saudi female infant who presented on the third day of life with persistent hyperkalemia, hyponatremia, and metabolic acidosis. Initial evaluation for congenital adrenal hyperplasia was unremarkable.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!